Peter K. Schulz-Knappe
Nessuna posizione attualmente
Storia della carriera di Peter K. Schulz-Knappe
Precedenti posizioni note di Peter K. Schulz-Knappe
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOVIA AB | Direttore Tecnico/Scientifico/R&S | - | 31/08/2020 |
| PROTEOME SCIENCES PLC | Direttore Tecnico/Scientifico/R&S | 05/10/2009 | 31/12/2009 |
Protagen AG
 Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Direttore Tecnico/Scientifico/R&S | 01/01/2010 | - |
| Corporate Officer/Principal | 05/05/2010 | 23/12/2014 | |
Digilab BioVisioN GmbH
 Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Direttore Tecnico/Scientifico/R&S | 01/11/1997 | - |
| Fondatore | 01/11/1997 | - |
Statistiche
Distribuzione geografica
| Germania | 3 |
| Regno Unito | 2 |
| Svezia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROTEOME SCIENCES PLC | Health Technology |
| IMMUNOVIA AB | Health Technology |
| Aziende private | 2 |
|---|---|
Digilab BioVisioN GmbH
Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Commercial Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany. | Health Technology |
